Patent · US Active

Pyruvate kinase activators for use in therapy

US9404081B2 · kind B2 · utility

11Cited by
6References
25Claims
0Family size

Assignee

Inventor

Key dates

Filing dateMay 3, 2012
Grant dateAug 2, 2016
Priority date—
Expiry dateAug 1, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D451/02
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Described herein are methods for using compounds that activate pyruvate kinase.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.